Cytek Biosciences (CTKB)
(Delayed Data from NSDQ)
$3.78 USD
-0.31 (-7.58%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.78 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Cytek Biosciences, Inc. - Hold
Zacks' proprietary data indicates that Cytek Biosciences, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CTKB shares relative to the market in the next few months. In addition, Cytek Biosciences, Inc. has a VGM Score of B (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that Cytek Biosciences, Inc. may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of CTKB, demonstrate its potential to perform inline with the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
Style Scorecard
Zacks News for CTKB
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates
CTKB: What are Zacks experts saying now?
Zacks Private Portfolio Services